Leaders from Australia’s medical technology sector have gathered in Perth for AusMedtech 2026 to explore innovation, translation and commercialisation across the medtech ecosystem.
Australia’s medtech industry, which includes more than 900 companies, is being cast as a critical driver of growth for the nation’s life sciences pipeline and economy.
For the first time, the conference features the WA Government’s Startup Alley, a dedicated space for early‑stage medtech and digital health companies to showcase innovations and connect with investors, clinicians and industry leaders from across Australia and overseas.
AusBiotech CEO Rebekah Cassidy said the event was creating the conditions for sectorwide collaboration.
“AusMedtech convenes the industry to drive critical conversations on the opportunities and challenges shaping the future of Australia’s innovative medtech sector, from development and manufacturing through to regulation and procurement.
“This event brings the sector together in a powerful way. Our program fosters meaningful dialogue across the ecosystem, at a time when collaboration has never been more important. As global dynamics continue to shift, from supply chain pressures to increasing healthcare needs, it is essential that Australia’s medtech sector remains connected, resilient, and future-focused.
“Medtech is central to advancing healthcare outcomes, strengthening health security, and supporting economic growth across Australia."
Western Australia’s Minister for Medical Research, Stephen Dawson, welcomed the showcase for local capability. “Hosting AusMedtech in Perth is a strong vote of confidence in Western Australia’s growing medtech capability.
“This event puts a spotlight on our researchers, innovators and companies, and connects them with global partners and investors. Through initiatives like the Future Health Research and Innovation Fund and targeted support for infrastructure, commercialisation and clinical trials, we are building a stronger, more competitive medtech sector in WA.”